Oral BPC-157 vs injections: why we went with capsules

July 24, 2026·3 min read
The short version

  • BPC-157 has historically been used as an injectable because peptides degrade in stomach acid.
  • Our formula uses an arginate salt plus an acidity-modulating stability matrix, so the payload survives the trip.
  • One capsule daily. No needles, no reconstitution, no sharps disposal, no refrigeration.
  • Every batch is third-party tested, and the lab report is yours on request.

The needle problem nobody talks about

If you have looked into BPC-157 before, you have seen the same setup: a vial of lyophilised powder, bacteriostatic water, insulin syringes, and a lot of instructions. It works, but it asks a lot of you. You reconstitute, you store cold, you dose by units, you dispose of sharps, and you repeat that several times a week.

For most people the compound was never the obstacle. The routine was. Protocols get abandoned somewhere around week three, not because nothing is happening, but because the ritual is heavy enough that one missed day becomes five.

Why capsules were hard until recently

Peptides are fragile in the stomach. Gastric acid and digestive enzymes break most of them apart long before they reach circulation, which is exactly why the injectable route became the default. An oral BPC-157 that is simply powder in a capsule is, for the most part, an expensive way to make acidic water.

Two things change that:

  • Arginate salt form. A stabilised 15-residue complex in arginate salt is considerably more robust than the free peptide in an acidic environment.
  • A stability matrix. Acidity-modulating excipients buffer the immediate environment around the active compound as the capsule transits the stomach.

Neither is exotic. Both are the difference between an oral format that delivers and one that does not.

Core 157™ pairs 500 mcg of BPC-157 Arginate with 450 mg of PEA in a single daily capsule. Two active components, no proprietary blend — you can read the entire formula in one line.

What you actually gain

  • Adherence. One capsule with or without food beats a four-step ritual, and adherence is what determines whether a 12-week window means anything.
  • Portability. A bottle travels. Vials, syringes and a cold chain do not, at least not comfortably.
  • No injection site issues. No bruising, no irritation, no technique to learn.
  • Simplicity of dosing. One capsule is one dose. There are no units to convert and no reconstitution maths to get wrong.

What we are not going to claim

Oral and injectable are different delivery routes with different pharmacokinetics. Anyone telling you the two are identical is selling something. What we will say is this: the format you will actually take every day for twelve weeks is the one worth choosing, and for most people that is not a syringe.

How to start

One capsule daily, with or without food, morning or evening. No loading phase, no cycling. Most people notice changes between weeks three and six, and sustained outcomes tend to build between weeks eight and twelve — which is why we sell it in six- and twelve-month protocols rather than single bottles.

Start with the full 12-week window, twice over.

See Core 157™ protocols

Three formulas. One standard.

Core 157™

Stack 157™

Gut 157™

Statements on this website have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. If you are taking prescription medication, have a medical condition, or are pregnant or nursing, consult your physician prior to use. Not for children. Results may vary.